Momenta Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2020 to a ratio of 15.01, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the second quarter 2020. Average receivable collection period, for the Momenta Pharmaceuticals Inc in Jun 30 2020 quarter, has decreased to 24 days, compared to 26 days, in the Mar 31 2020 quarter.

If we take a look into Healthcare sector 509 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2020 from 3503 to 3549.

What is Receivable Turnover Ratio?
What is Momenta Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MNTA Receivables Turnover Ratio	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter
Y / Y Receivable Change	-	-	-29.53 %	-	-
Y / Y Revenue Change	27.56 %	116.12 %	-80.89 %	-57.06 %	-60.23 %
Receivable Turnover Ratio (TTM)	15.01	14.3	11.91	20.58	23.57
MNTA's Total Ranking	# 3549	# 3503	# 3518	# 3518	# 3518
Accounts Receivable average collection period days	24	26	31	18	15
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-25.64 %	8.64 %	28.02 %	23.33 %	25.99 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 46
Healthcare Sector	# 510
Overall Market	# 3549

Receivable Turnover Ratio Statistics
High	Average	Low
0.28	0.18	0.05
(Jun 30 2015)		(Dec 31 2019)

MNTA Company Profile • Back to MNTA Efficiency Comparisons • Compare MNTA Receivables Turnover Ratio to its Competitors

Financial Statements
Momenta Pharmaceuticals Inc 's Accounts Receivable	$ 0 Millions	Visit MNTA's Balance sheet
Momenta Pharmaceuticals Inc 's Sales TTM	$ 30 Millions	Visit MNTA's Income Statement
Sources of MNTA's Revenues		Visit MNTA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MNTA's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MNTA's Growth Rates	MNTA's Roa	MNTA's Inventory Turnover Ratio	MNTA's Dividend Comparisons
MNTA's Profitability Ratios	MNTA's Roi	MNTA's Asset Turnover Ratio	MNTA's Dividend Growth
MNTA's Valuation Ratios	MNTA's Roe	MNTA's Financial Strength Ratios	MNTA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2020, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Jun 30 2020

Receivable at quarter ending Jun 30 2020

Date modified: 2026-08-29T17:26:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.